MARKET

BIVI

BIVI

Biovie Inc
NASDAQ
1.610
+0.020
+1.26%
Closed 18:46 12/04 EST
OPEN
1.590
PREV CLOSE
1.590
HIGH
1.700
LOW
1.560
VOLUME
128.91K
TURNOVER
0
52 WEEK HIGH
31.50
52 WEEK LOW
1.250
MARKET CAP
12.14M
P/E (TTM)
-0.1805
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BIVI last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at BIVI last week (1117-1121)?
Weekly Report · 11/24 09:34
Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound
NASDAQ · 11/21 04:39
Weekly Report: what happened at BIVI last week (1110-1114)?
Weekly Report · 11/17 09:34
BioVie Stockholders Approve Key Proposals at Annual Meeting
TipRanks · 11/12 22:37
BioVie Q1 EPS $(0.98) Misses $(0.79) Estimate
Benzinga · 11/10 22:43
Weekly Report: what happened at BIVI last week (1103-1107)?
Weekly Report · 11/10 09:33
Weekly Report: what happened at BIVI last week (1027-1031)?
Weekly Report · 11/03 09:32
More
About BIVI
BioVie Inc. is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. In neurodegenerative disease, the Company's drug candidate bezisterim inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor nuclear factor-kB, and the associated neuroinflammation and insulin resistance, but not ERK and NFkB homeostatic functions (such as insulin signaling and neuron growth and survival). Both neuroinflammation and insulin resistance are drivers of Alzheimer’s disease (AD) and Parkinson’s disease (PD). Persistent systematic inflammation and neuroinflammation are key features in patients with neurological symptoms of long COVID. In liver disease, the Company's orphan drug candidate BIV201, is being evaluated for Phase III clinical testing for the reduction of further decompensation in participants with liver cirrhosis and ascites.

Webull offers BioVie Inc stock information, including NASDAQ: BIVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIVI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIVI stock methods without spending real money on the virtual paper trading platform.